Literature DB >> 19174807

Management of Crohn's disease in adults.

Gary R Lichtenstein1, Stephen B Hanauer, William J Sandborn.   

Abstract

Guidelines for clinical practice are intended to suggest preferable approaches to particular medical problems as established by interpretation and collation of scientifically valid research, derived from extensive review of published literature. When data that will withstand objective scrutiny are not available, a recommendation may be made based on a consensus of experts. Guidelines are intended to apply to the clinical situation for all physicians without regard to specialty. Guidelines are intended to be flexible, not necessarily indicating the only acceptable approach, and should be distinguished from standards of care that are inflexible and rarely violated. Given the wide range of choices in any health-care problem, the physician should select the course best suited to the individual patient and the clinical situation presented. These guidelines are developed under the auspices of the American College of Gastroenterology and its Practice Parameters Committee. Expert opinion is solicited from the outset for the document. The quality of evidence upon which a specific recommendation is based is as follows: Grade A: Homogeneous evidence from multiple well-designed randomized (therapeutic) or cohort (descriptive) controlled trials, each involving a number of participants to be of sufficient statistical power. Grade B: Evidence from at least one large well-designed clinical trial with or without randomization, from cohort or case-control analytic studies, or well-designed meta-analysis. Grade C: Evidence based on clinical experience, descriptive studies, or reports of expert committees. The Committee reviews guidelines in depth, with participation from experienced clinicians and others in related fields. The final recommendations are based on the data available at the time of the production of the document and may be updated with pertinent scientific developments at a later time.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19174807     DOI: 10.1038/ajg.2008.168

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  255 in total

Review 1.  Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.

Authors:  Kara Bradford; David Q Shih
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

2.  Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.

Authors:  Rotonya M Carr; Arpan Patel; Hillary Bownik; Amanke Oranu; Caroline Kerner; Amy Praestgaard; Kimberly A Forde; K Rajender Reddy; Gary R Lichtenstein
Journal:  Dig Dis Sci       Date:  2017-03-06       Impact factor: 3.199

3.  Crohn's disease diagnosis following discovery of in situ follicular lymphoma.

Authors:  Chad L McDonald; Pablo J Calzada
Journal:  Gastrointest Cancer Res       Date:  2011-09

Review 4.  An update of the role of nutritional therapy in the management of Crohn's disease.

Authors:  Moftah H Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2012-06-15       Impact factor: 7.527

5.  Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet.

Authors:  Mitsuro Chiba; Toru Abe; Hidehiko Tsuda; Takeshi Sugawara; Satoko Tsuda; Haruhiko Tozawa; Katsuhiko Fujiwara; Hideo Imai
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

6.  New Data on the Use of Biologic Agents for Crohn's Disease and Ulcerative Colitis: Highlights from the 2009 CCFA Advances in IBD Meeting.

Authors:  Edward V Loftus
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-02

7.  Biologic Therapies for Crohn's Disease: Update from the 2009 ACG Meeting.

Authors:  David G Binion
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-01

8.  Quantitative Inflammation Assessment for Crohn Disease Using Ultrasensitive Ultrasound Microvessel Imaging: A Pilot Study.

Authors:  Ping Gong; Pengfei Song; Amy B Kolbe; Shannon P Sheedy; Chengwu Huang; Wenwu Ling; Yue Yu; Chenyun Zhou; U Wai Lok; Shanshan Tang; David H Bruining; John M Knudsen; Shigao Chen
Journal:  J Ultrasound Med       Date:  2020-04-16       Impact factor: 2.153

Review 9.  Use of exclusive enteral nutrition in adults with Crohn's disease: a review.

Authors:  Catherine L Wall; Andrew S Day; Richard B Gearry
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 10.  A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors:  David Kim; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.